Provided herein in part is a method of treating a neurological or movement disorder in a patient in need thereof comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone or pharmaceutically acceptable salts thereof wherein said composition is administered substantially continuously and compositions that can be used in the disclosed methods.